Technology in the management of type 1 diabetes mellitus - current status and future prospects (Q56516887)

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Convenient pocket insulin syringe

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Insulin pump use in Europe

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus - systematic review

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The effect of bolus and food calculator Diabetics on glucose variability in children with type 1 diabetes treated with insulin pump: the results of RCT.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatment

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Young people with Type 1 diabetes of non-white ethnicity and lower socio-economic status have poorer glycaemic control in England and Wales

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and monitoring of glycemic control in children and adolescents with diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study).

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous glucose monitoring: transforming diabetes management step by step

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, th

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

International Consensus on Use of Continuous Glucose Monitoring.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous glucose monitoring and intensive treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Real-time continuous glucose monitoring system for treatment of diabetes: a systematic review

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

An alternative sensor-based method for glucose monitoring in children and young people with diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Improvement in Glucose Control in Difficult-to-Control Patients With Diabetes Using a Novel Flash Glucose Monitoring Device

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Flash Glucose Monitoring Improves Outcomes in a Type 1 Diabetes Clinic.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Flash Glucose Monitoring is associated with improved glycaemic control but use is largely limited to more affluent people in a UK diabetes centre

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Threshold-based insulin-pump interruption for reduction of hypoglycemia

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Prevention of Hypoglycemia by Using Low Glucose Suspend Function in Sensor-Augmented Pump Therapy

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Predictive Low-Glucose Insulin Suspension Reduces Duration of Nocturnal Hypoglycemia in Children Without Increasing Ketosis

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Feasibility of automating insulin delivery for the treatment of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A bihormonal closed-loop artificial pancreas for type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Home Use of an Artificial Beta Cell in Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Real-World Use of Open Source Artificial Pancreas Systems

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Distal technologies and type 1 diabetes management

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A Minority of Patients with Type 1 Diabetes Routinely Downloads and Retrospectively Reviews Device Data.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Downloading Diabetes Device Data: Empowering Patients to Download at Home to Achieve Better Outcomes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A Patient-Designed Do-It-Yourself Mobile Technology System for Diabetes: Promise and Challenges for a New Era in Medicine

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The Use of Mobile Applications Among Adolescents with Type 1 Diabetes: Results from Diabetes MILES Youth-Australia

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Improving diabetes care for young people with type 1 diabetes through visual learning on mobile phones: mixed-methods study

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Computerized Automated Reminder Diabetes System (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Design of an mHealth app for the self-management of adolescent type 1 diabetes: a pilot study

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A Mobile App for the Self-Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Regulation Catches Up to Reality

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

"Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Trends in FDA regulation of software to control insulin dosing

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Finding the right route for insulin delivery - an overview of implantable pump therapy

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Use of the site of subcutaneous insulin administration for the measurement of glucose in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

The role of glucagon in the artificial pancreas

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Outpatient glycemic control with a bionic pancreas in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Development of glucose-responsive 'smart' insulin systems

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021

Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases.

1 reference

https://api.crossref.org/works/10.1038/S41574-018-0044-Y

7 January 2021